Phase 3, open-label, multi-center, double-blind, randomized, parallel group study efficacy and safety of fixed combination torcetrapib/atorvastatin, administered once daily compared to fixed combination ezetimibe/simvastatin for 6 weeks in subjects with dyslipidemia

Trial Profile

Phase 3, open-label, multi-center, double-blind, randomized, parallel group study efficacy and safety of fixed combination torcetrapib/atorvastatin, administered once daily compared to fixed combination ezetimibe/simvastatin for 6 weeks in subjects with dyslipidemia

Discontinued
Phase of Trial: Phase III

Latest Information Update: 05 Dec 2006

At a glance

  • Drugs Ezetimibe/simvastatin; Torcetrapib/atorvastatin
  • Indications Lipid metabolism disorders
  • Focus Biomarker; Registrational; Therapeutic Use
  • Sponsors Pfizer
  • Most Recent Events

    • 05 Dec 2006 Status change
    • 18 Aug 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top